Neumora Therapeutics (NMRA) Treasury Shares (2022 - 2026)

Neumora Therapeutics' Treasury Shares history runs 5 years deep, the most recent figure standing at $58000.0 for Q1 2026.

• In Q1 2026, Treasury Shares fell 47.75% year-over-year to $58000.0; the TTM figure through Mar 2026 stood at $58000.0 (down 47.75% YoY), while the FY2025 annual figure was $662000.0, down 54.06% from the prior year.
• Treasury Shares was $58000.0 for Q1 2026 at Neumora Therapeutics, down from $662000.0 in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $2.9 million in Q4 2022 to a low of $58000.0 in Q1 2026.
• Historically, Treasury Shares has averaged $882916.7 across 5 years, with a median of $663000.0 in 2025.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares jumped 71.55% in 2024, then tumbled 92.64% in 2025.
• A 5-year view of Treasury Shares shows it stood at $2.9 million in 2022, then tumbled by 71.05% to $840000.0 in 2023, then surged by 71.55% to $1.4 million in 2024, then sank by 54.06% to $662000.0 in 2025, then plunged by 91.24% to $58000.0 in 2026.
• The last three Treasury Shares figures came in at $58000.0 (Q1 2026), $662000.0 (Q4 2025), and $85000.0 (Q3 2025), per Business Quant data.